Omada Health CFO Steven Cook Sells Shares
Omada Health's CFO, Steven Cook, sold 2,600 shares in a planned transaction.
Key Points
- On June 24, 2026, Omada Health's CFO Steven Cook sold 2,600 shares at $19.02 each, totaling $49,452.
- Omada Health trades on NasdaqGS under the ticker OMDA, with a market cap of about $1.12 billion and a forward P/E ratio of 39.67.
- Morgan Stanley reiterated a 'buy' rating on June 22, 2026, with a $30 price target, while other analysts maintain positive views.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Steven Cook, the Chief Financial Officer of Omada Health, Inc. (NasdaqGS: OMDA), sold 2,600 shares of the company on June 24, 2026. The shares were sold at an average price of $19.02 each, totaling $49,452. This transaction was planned under a Rule 10b5-1 trading plan, which allows insiders to set up a schedule for selling stocks to avoid accusations of insider trading.
Insider Buying and Selling at Omada Health, Inc.
In addition to Cook's sale, Omada Health saw several other insider transactions. CEO Sean Duffy sold 2,800 shares on June 24, 2026, at $19.01 each. Craig Gracey, the Chief Accounting Officer, also sold 2,083 shares on the same day at $19.01. These sales were part of planned transactions as well.
Omada Health, Inc. Stock Down 11.8%
Shares of Omada Health traded near $20.89 on Saturday. The company, which is listed on the NasdaqGS under the ticker OMDA, has a market capitalization of approximately $1.12 billion. It has a forward P/E ratio of 39.67, indicating how much investors are willing to pay for the company's future earnings. Over the past 52 weeks, the stock has ranged from $10.28 to $26.92. Its 50-day moving average is $16.29, and the 200-day moving average is $17.15. Omada Health maintains a strong liquidity position with a current ratio of 3.92 and a quick ratio of 3.69.
$OMDA stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On June 22, 2026, Morgan Stanley reiterated its 'buy' rating for Omada Health, setting a price target of $30. Barclays, Citizens, and Evercore ISI Group have also maintained their 'buy' ratings in recent months, with price targets ranging from $15 to $23. The consensus among 12 analysts is a 'buy' rating, with a mean target price of $22.92.
About Omada Health
Omada Health, Inc. provides virtual care programs, focusing on cardiometabolic conditions like prediabetes, diabetes, and hypertension. The company also offers physical therapy and behavioral health support programs. Headquartered in South San Francisco, California, Omada Health works with employers, health plans, and systems to deliver its services. Led by CEO Sean P. Duffy, the company employs around 943 people and was founded in 2011.
Bottom Line
Insider transactions at Omada Health, such as those by CFO Steven Cook, are part of planned sales and don't necessarily indicate negative sentiment. Investors often watch such sales closely as part of their due diligence. Omada Health's stock, with its strong market position and analyst support, remains of interest. However, it's important to remember that these insider sales are disclosed after the fact and are part of routine filings.
Get Omada Health, Inc. alerts
New 13F filings, insider trades, and analyst moves on $OMDA, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.